THBD and COVID-19: Increased levels of thrombomodulin (CD141), a cofactor for thrombin reducing blood coagulation, possibly possessing an anticoagulant potential, were observed on cMonos in both moderate and severe disease, and on iMonos and ncMonos in severe COVID-19.